vs
科迪华(CTVA)与SMITH MIDLAND CORP(SMID)财务数据对比。点击上方公司名可切换其他公司
科迪华的季度营收约是SMITH MIDLAND CORP的169.2倍($3.9B vs $23.1M)。SMITH MIDLAND CORP净利率更高(9.2% vs -14.1%,领先23.3%)。SMITH MIDLAND CORP同比增速更快(24.7% vs -1.7%)。过去两年SMITH MIDLAND CORP的营收复合增速更高(17.4% vs -6.7%)
科迪华是一家美国农业科技企业,主营种子与作物保护产品,涵盖除草剂、杀虫剂、杀菌剂及生物制剂,业务覆盖全球110个国家,总部位于印第安纳州印第安纳波利斯,旗下大部分种子产品以先锋良种国际品牌销售。
Smith Midland Corp是一家预制混凝土产品专业制造商,核心产品线包括公路安全护栏、隔音墙、建筑预制面板及雨水管理系统,主要服务北美市场,为各类基建、商用、住宅及工业建筑项目提供耐用可持续的建筑解决方案。
CTVA vs SMID — 直观对比
营收规模更大
CTVA
是对方的169.2倍
$23.1M
营收增速更快
SMID
高出26.4%
-1.7%
净利率更高
SMID
高出23.3%
-14.1%
两年增速更快
SMID
近两年复合增速
-6.7%
损益表 — Q4 2025 vs Q4 2025
| 指标 | ||
|---|---|---|
| 营收 | $3.9B | $23.1M |
| 净利润 | $-552.0M | $2.1M |
| 毛利率 | 42.4% | 57.5% |
| 营业利润率 | -13.6% | 37.8% |
| 净利率 | -14.1% | 9.2% |
| 营收同比 | -1.7% | 24.7% |
| 净利润同比 | -1246.3% | 52.5% |
| 每股收益(稀释后) | $-0.80 | $0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CTVA
SMID
| Q4 25 | $3.9B | $23.1M | ||
| Q3 25 | $2.6B | $21.5M | ||
| Q2 25 | $6.5B | $26.2M | ||
| Q1 25 | $4.4B | $22.7M | ||
| Q4 24 | $4.0B | $18.5M | ||
| Q3 24 | $2.3B | $23.6M | ||
| Q2 24 | $6.1B | $19.6M | ||
| Q1 24 | $4.5B | $16.8M |
净利润
CTVA
SMID
| Q4 25 | $-552.0M | $2.1M | ||
| Q3 25 | $-320.0M | $2.9M | ||
| Q2 25 | $1.3B | $4.2M | ||
| Q1 25 | $652.0M | $3.3M | ||
| Q4 24 | $-41.0M | $1.4M | ||
| Q3 24 | $-524.0M | $3.1M | ||
| Q2 24 | $1.1B | $2.0M | ||
| Q1 24 | $419.0M | $1.1M |
毛利率
CTVA
SMID
| Q4 25 | 42.4% | 57.5% | ||
| Q3 25 | 37.2% | 26.8% | ||
| Q2 25 | 54.6% | 0.0% | ||
| Q1 25 | 47.0% | 30.7% | ||
| Q4 24 | 37.3% | 51.4% | ||
| Q3 24 | 32.7% | 27.9% | ||
| Q2 24 | 52.3% | 0.0% | ||
| Q1 24 | 43.2% | 23.3% |
营业利润率
CTVA
SMID
| Q4 25 | -13.6% | 37.8% | ||
| Q3 25 | -14.1% | 18.0% | ||
| Q2 25 | 27.9% | 0.0% | ||
| Q1 25 | 17.7% | 19.3% | ||
| Q4 24 | 2.2% | 24.5% | ||
| Q3 24 | -27.2% | 16.3% | ||
| Q2 24 | 21.9% | 0.0% | ||
| Q1 24 | 10.7% | 9.0% |
净利率
CTVA
SMID
| Q4 25 | -14.1% | 9.2% | ||
| Q3 25 | -12.2% | 13.4% | ||
| Q2 25 | 20.4% | 15.9% | ||
| Q1 25 | 14.8% | 14.7% | ||
| Q4 24 | -1.0% | 7.5% | ||
| Q3 24 | -22.5% | 13.4% | ||
| Q2 24 | 17.2% | 10.1% | ||
| Q1 24 | 9.3% | 6.8% |
每股收益(稀释后)
CTVA
SMID
| Q4 25 | $-0.80 | $0.41 | ||
| Q3 25 | $-0.47 | $0.54 | ||
| Q2 25 | $1.92 | $0.79 | ||
| Q1 25 | $0.95 | $0.62 | ||
| Q4 24 | $-0.05 | $0.28 | ||
| Q3 24 | $-0.76 | $0.59 | ||
| Q2 24 | $1.51 | $0.37 | ||
| Q1 24 | $0.60 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | — |
| 总债务越低越好 | $1.7B | — |
| 股东权益账面价值 | $24.1B | $54.3M |
| 总资产 | $42.8B | $87.7M |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势,按日历期对齐
现金及短期投资
CTVA
SMID
| Q4 25 | $4.5B | — | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $3.2B | — | ||
| Q3 24 | $2.5B | — | ||
| Q2 24 | $2.0B | — | ||
| Q1 24 | $1.7B | — |
总债务
CTVA
SMID
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.8B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $2.5B | — | ||
| Q1 24 | $2.5B | — |
股东权益
CTVA
SMID
| Q4 25 | $24.1B | $54.3M | ||
| Q3 25 | $25.2B | $52.1M | ||
| Q2 25 | $25.9B | $49.2M | ||
| Q1 25 | $24.3B | $45.1M | ||
| Q4 24 | $23.8B | $41.7M | ||
| Q3 24 | $24.7B | $40.3M | ||
| Q2 24 | $25.2B | $37.2M | ||
| Q1 24 | $24.8B | $35.3M |
总资产
CTVA
SMID
| Q4 25 | $42.8B | $87.7M | ||
| Q3 25 | $42.2B | $85.4M | ||
| Q2 25 | $41.8B | $81.2K | ||
| Q1 25 | $42.1B | $74.7M | ||
| Q4 24 | $40.8B | $68.0M | ||
| Q3 24 | $41.9B | $66.6M | ||
| Q2 24 | $41.5B | $64.0M | ||
| Q1 24 | $43.6B | $64.9M |
负债/权益比
CTVA
SMID
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.07× | — | ||
| Q2 25 | 0.07× | — | ||
| Q1 25 | 0.07× | — | ||
| Q4 24 | 0.08× | — | ||
| Q3 24 | 0.08× | — | ||
| Q2 24 | 0.10× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $4.4B | — |
| 自由现金流经营现金流 - 资本支出 | $4.2B | — |
| 自由现金流率自由现金流/营收 | 106.2% | — |
| 资本支出强度资本支出/营收 | 5.7% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $2.8B | — |
8季度趋势,按日历期对齐
经营现金流
CTVA
SMID
| Q4 25 | $4.4B | — | ||
| Q3 25 | $193.0M | $11.7M | ||
| Q2 25 | $947.0M | — | ||
| Q1 25 | $-2.1B | $2.2M | ||
| Q4 24 | $4.2B | $-645.0K | ||
| Q3 24 | $130.0M | $3.9M | ||
| Q2 24 | $451.0M | $2.7M | ||
| Q1 24 | $-2.6B | $-777.0K |
自由现金流
CTVA
SMID
| Q4 25 | $4.2B | — | ||
| Q3 25 | $36.0M | $6.3M | ||
| Q2 25 | $829.0M | — | ||
| Q1 25 | $-2.2B | $1.6M | ||
| Q4 24 | $4.0B | $-1.3M | ||
| Q3 24 | $-24.0M | $1.8M | ||
| Q2 24 | $337.0M | $998.0K | ||
| Q1 24 | $-2.8B | $-2.6M |
自由现金流率
CTVA
SMID
| Q4 25 | 106.2% | — | ||
| Q3 25 | 1.4% | 29.5% | ||
| Q2 25 | 12.8% | — | ||
| Q1 25 | -49.9% | 7.1% | ||
| Q4 24 | 100.4% | -7.0% | ||
| Q3 24 | -1.0% | 7.8% | ||
| Q2 24 | 5.5% | 5.1% | ||
| Q1 24 | -61.4% | -15.3% |
资本支出强度
CTVA
SMID
| Q4 25 | 5.7% | — | ||
| Q3 25 | 6.0% | 25.1% | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 2.1% | 2.6% | ||
| Q4 24 | 4.6% | 3.6% | ||
| Q3 24 | 6.6% | 8.6% | ||
| Q2 24 | 1.9% | 8.7% | ||
| Q1 24 | 3.3% | 10.7% |
现金转化率
CTVA
SMID
| Q4 25 | — | — | ||
| Q3 25 | — | 4.07× | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | -3.23× | 0.67× | ||
| Q4 24 | — | -0.46× | ||
| Q3 24 | — | 1.23× | ||
| Q2 24 | 0.43× | 1.37× | ||
| Q1 24 | -6.23× | -0.68× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTVA
| Corn | $1.4B | 35% |
| Herbicides | $1.1B | 27% |
| Insecticides | $488.0M | 12% |
| Fungicides | $272.0M | 7% |
| Biologicals | $191.0M | 5% |
| Soybean | $164.0M | 4% |
| Other | $160.0M | 4% |
| Otheroilseeds | $94.0M | 2% |
SMID
| Product Sales | $13.8M | 60% |
| Service Revenue | $9.3M | 40% |